Type 2 & other diabetes

Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

In the diabetic population, elevated plasma levels of hs-cTnT, hs-cTnI, NT-proBNP, creatinine, cystatin C, and β-2 microglobulin serve as robust and straightforward predictors of long-term mortality compared to blood glucose levels and HbA1c values. Creatinine and cystatin C stand out as more precise markers for predicting diabetes mortality prior to blood glucose monitoring.

Study context

Population
Adults with diabetes in the U.S. National Health and Nutrition Examination Survey (NHANES)
Participants
1,783 adults
Exposure
Cardio-renal blood biomarkers vs traditional risk factors and blood glucose monitoring for mortality prediction
Outcome
All-cause mortality
Follow-up
Median 7.42 years
Methodological detailsmultivariable Cox proportional hazards regression, NHANES
  • Multivariable Cox proportional hazards regression
  • NHANES

Main finding

As reported in the abstract

Improvement in predictive ability for all-cause mortality vs traditional risk factors
Addition of hs-cTnT
56.4%
Addition of hs-cTnI
29.5%
Addition of NT-proBNP
38.1%
Addition of creatinine
18.8%
Addition of cystatin C
35.7%
Addition of β-2 microglobulin
41.3%

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Diabetes mortality by creatinine quartile · median follow-up 7.42 yearsHighest quartilesvs 1st quartilesCreatinine; higher risk in highest quartile5.16 (1.87–14.22)
Diabetes mortality by cystatin C quartile · median follow-up 7.42 yearsHighest quartilesvs 1st quartilesCystatin C; higher risk in highest quartile10.06 (4.20–24.13)

Original publication

Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study. Cardiovasc Diabetol. Published 29 September 2023. doi:10.1186/s12933-023-01986-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.